Lupin and I'rom signs licensing agreement for Denosumab biosimilar for Japan

Pristyn Care witnesses industry highest adoption of EMR

99% of Pristyn Doctors are using EMR facility on its doctor app

Lupin to acquire brands Ondero and Ondero - Met from Boehringer Ingelheim

The cash consideration for the above acquisition will be Euro 26 million.

Unichem Laboratories receives ANDA approval for Carbamazepine Tablets

Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia

3Brain AG's Accura-3D microchip, enters the market

3D CMOS chip for connecting electroactive tissues and organoids to software

Merck gets fast track designation from the USFDA for anticoagulant therapy

Phase 2 Study of MK-2060 Currently Ongoing in People with End-Stage Renal Disease Receiving Hemodialysis

Nursing and Midwifery associations call out the urgent need for policy support to drive a robust health workforce in India

Today, India stands at 1.7 nurses per 1,000 population, as opposed to the World Health Organization norm of 3 nurses per 1000.

Jaslok Hospital launches coordination center in Oman

The citizens of Oman will soon have a coordination center that will provide end to end services for healthcare facilities of Jaslok.

PM to inaugurate Amrita Hospital and Homi Bhabha Cancer Hospital & Research Centre

The hospital is being constructed at an estimated cost of around Rs. 6,000 crore and will provide healthcare facilities to the people of Faridabad and the entire NCR region

DCGI approves AstraZeneca 's Olaparib film-coated tablets

Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer